RxDoctor Payments Data

Farzad Nahai, MD

Plastic Surgery · Atlanta, GANPI 1801870175

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $120,048 of the $128,839 with a category attached, or 93.2%. Musculoskeletal Transplant Foundation Inc. accounts for 94.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $39,859 and has fallen 97.8% since, to $882 in 2025. Among plastic surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$128,839in general payments, 2019–2025

Across 167 payments — averaging $771.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$122K
  • Galderma Laboratories, L.p.$2K
  • AbbVie$2K
  • Revance Therapeutics, Inc.$754
  • Merz North America, Inc.$695
  • Sientra, Inc.$261
  • plus $887 from 13 others
$309,102in research payments, 2019–2025

Across 15 payments — averaging $20,607 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merz North America, Inc.$303K
  • Musculoskeletal Transplant Foundation Inc.$5K
  • Sientra, Inc.$750

What the payments were for

  • Consulting fees$120,04893%
  • Speaking & faculty fees$1250%
  • Travel & lodging$3,1012%
  • Food & beverage$5,5654%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$128,839 in reported general payments places this provider in the 95th percentile of 163 plastic surgery providers in Georgia.

See all plastic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$93,406
Medicare patients
124
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate75$324
Mupirocin43$293
Acetaminophen-CodeineAcetaminophen With Codeine23$113
Tramadol Hcl20$34
Alprazolam19$26

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →